MTNB vs PG · rev $1.1M vs P/E 25, rev $84.28B
Matinas BioPharma Holdings Inc (MTNB) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported MTNB revenue for 2023-12-31 was $1.1M. Net income was -$22.9M. Revenue was down 65.6% from 2022-12-31 to 2023-12-31. MTNB currently screens at market cap $5.6M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
MTNB currently screens at market cap $5.6M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the MTNB and PG stock pages for the full models.
Not investment advice.